Columbia Psychiatry Pathways 3.28.7

Developed by expert psychiatrists from Columbia University and powered by avoMD's state-of-the-art interactive technology, this evidence-based application offers a pragmatic and user-friendly treatment algorithm for major depression.

The app integrates Columbia’s Accelerated Sequential Antidepressant Protocol (ASAP) © 2021 The Trustees of Columbia University in the City of New York. It includes tools to evaluate depression severity (PHQ-9 and Columbia Depression Scale), conduct bipolar screenings, and assess suicide risk, consolidating all essential information for managing depression in one easily accessible platform. Additionally, it features clinical insights on antidepressant titration and the management of common side effects.

A modernized version of the STAR*D Trial from 2006, ASAP emphasizes prompt titrations and follow-ups centered around the seven best-tolerated generic antidepressants, streamlining the process of treating depression.

Targeted for utilization in outpatient settings by psychiatrists, primary care physicians, nurse practitioners, physician assistants, medical students, residents, and trainees dealing with patients suffering from depression, Columbia Psychiatry Pathways serves as a valuable resource.

• Developed by experts at Columbia University's Department of Psychiatry in collaboration with avoMD
• Regularly updated to align with the most recent research findings and supplemented with external resources
• Offers clinical pearls on depression treatment, including guidance on titration strategies, side effect management, and more
• Covers the seven essential medications for effectively managing outpatient depression
• Includes recommendations for handling DSM-5 depression as well as screening for bipolar disorder and suicide risk
• Provides built-in calculators for measuring symptom severity using the Patient Health Questionnaire-9 item (PHQ-9) and the Columbia Depression Scale
• Aids psychiatrists, primary care physicians, nurse practitioners, physician assistants, and trainees in making real-time psychopharmacologic decisions in outpatient settings
• Serves as an educational tool for program directors, residents, medical students, and other trainees

Ranked among the top five psychiatry hospitals nationally by US News and receiving the #3 spot in NIH funding, Columbia University’s Department of Psychiatry boasts a rich history of over a century in academic psychiatry. The department's faculty have played pivotal roles in shaping psychiatric practices globally. Notable figures behind this clinical algorithm are J. John Mann, MD, co-director of Columbia’s Center for the Prevention and Treatment of Depression and a renowned researcher in mood disorders, along with Ravi N. Shah, MD, MBA, an influential figure in digital mental health serving as the department’s Chief Innovation Officer.

avoMD specializes in converting clinical guidelines, pathways, and algorithms into interactive decision support applications that are accessible as standalone mobile apps, web apps, or integrated within EHR systems. Hospitals and training programs nationwide are leveraging avoMD to digitalize their clinical resources and distribute them efficiently. Noteworthy supporters include Columbia University’s Lang Entrepreneurship Center, Mount Sinai Innovation Partners’ Elementa Labs, StartUp Health, and 500 Startups. The experienced team at avoMD comprises physicians and informaticians from prestigious institutions such as Columbia, Harvard, and Yale.

Subscription cost is $19.99 per year with automatic renewal unless disabled. Cancellations should be made at least 24 hours before renewal to avoid charges. Subscription management can be handled through your Apple ID account settings post-purchase.